YUBNUB.NEWS
Second Patient Dies After Gene Therapy for Duchenne Muscular Dystrophy: Company
Sarepta, the company that makes the drug, is pausing it for non-ambulatory patients.A second patient has died after receiving the gene therapy Elevidys, which was approved by the Food and Drug Administration
0 Commenti 0 condivisioni 32 Views